Both in Pharmaceuticals
Fulcrum Therapeutics vs Q32 Bio
Over the past year FULC returned −57.3% and QTTB returned +391.2%; their daily moves had a correlation of -0.03.
FULC −57.3% QTTB +391.2%Growth of $1, one year, split-adjusted
| Metric | FULC | QTTB |
|---|---|---|
| Price | $3.70 | $9.53 |
| Market cap | $282.3M | $283.7M |
| Today | −0.54% | +3.25% |
| 1 month | −3.9% | −36.6% |
| 6 months | −43.8% | +61.5% |
| Year to date | −67.3% | +187.0% |
| 1 year | −58.1% | +404.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 8.4× |
| Price / sales | — | 5.3× |
| Net cash | $318.8M | $106.3M |
| Dividend yield | — | — |
| Volatility (60d) | 25.4% | 153.8% |
| Short % of float | 11.3% | 30.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).